RestorGenex - 48 Year Dividend History | DFFN

Historical dividend payout and yield for RestorGenex (DFFN) since 1971. The current TTM dividend payout for RestorGenex (DFFN) as of June 25, 2019 is $0.00. The current dividend yield for RestorGenex as of June 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.010B $0.000B
Diffusion Pharmaceuticals Inc. is a biotechnology company. Its product pipeline includes Trans Sodium Crocetinate, Glioblastoma Program, Pancreatic Cancer Program and Brain Metastases Program. The Company is focused on cancer treatments, such as radiation therapy and chemotherapy in treatment-resistant solid tumors. Diffusion Pharmaceuticals Inc., formerly known as RestorGenex Corporation, is based in Charlottesville, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.734B 12.75
Gilead Sciences (GILD) United States $87.764B 10.66
Bio-Techne Corp (TECH) United States $7.796B 53.19